SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,168 | -53.2% | 215,297 | +1.5% | 0.00% | – |
| Q2 2023 | $275,779 | +74636.9% | 212,138 | +1.1% | 0.00% | – |
| Q1 2023 | $369 | -39.4% | 209,769 | +8.1% | 0.00% | -100.0% |
| Q4 2022 | $609 | -99.9% | 194,096 | +3.1% | 0.00% | 0.0% |
| Q3 2022 | $923,000 | +29.8% | 188,334 | +9.7% | 0.00% | 0.0% |
| Q2 2022 | $711,000 | -7.1% | 171,733 | +30.4% | 0.00% | 0.0% |
| Q1 2022 | $765,000 | -27.1% | 131,705 | -5.9% | 0.00% | 0.0% |
| Q4 2021 | $1,050,000 | -18.0% | 139,954 | -1.5% | 0.00% | -50.0% |
| Q3 2021 | $1,280,000 | -22.4% | 142,100 | +3.1% | 0.00% | 0.0% |
| Q2 2021 | $1,650,000 | -8.9% | 137,815 | -4.6% | 0.00% | 0.0% |
| Q1 2021 | $1,811,000 | -25.9% | 144,510 | -7.7% | 0.00% | -33.3% |
| Q4 2020 | $2,444,000 | +71.0% | 156,627 | +3.6% | 0.00% | +50.0% |
| Q3 2020 | $1,429,000 | -17.7% | 151,246 | -21.9% | 0.00% | -33.3% |
| Q2 2020 | $1,736,000 | +60.7% | 193,750 | +14.3% | 0.00% | +50.0% |
| Q1 2020 | $1,080,000 | -21.1% | 169,564 | +3.6% | 0.00% | 0.0% |
| Q4 2019 | $1,369,000 | -3.3% | 163,594 | +4.6% | 0.00% | -33.3% |
| Q3 2019 | $1,416,000 | -12.8% | 156,420 | +3.8% | 0.00% | 0.0% |
| Q2 2019 | $1,623,000 | +28.3% | 150,737 | +13.7% | 0.00% | +50.0% |
| Q1 2019 | $1,265,000 | -18.1% | 132,599 | -1.5% | 0.00% | -33.3% |
| Q4 2018 | $1,545,000 | -0.1% | 134,623 | +47.6% | 0.00% | 0.0% |
| Q3 2018 | $1,546,000 | +11.4% | 91,205 | -6.7% | 0.00% | 0.0% |
| Q2 2018 | $1,388,000 | -7.5% | 97,760 | +23.8% | 0.00% | 0.0% |
| Q1 2018 | $1,500,000 | +15.7% | 78,945 | -0.1% | 0.00% | 0.0% |
| Q4 2017 | $1,296,000 | -2.7% | 79,032 | -11.0% | 0.00% | 0.0% |
| Q3 2017 | $1,332,000 | +83.0% | 88,816 | +7.4% | 0.00% | +50.0% |
| Q2 2017 | $728,000 | +64.7% | 82,691 | -2.8% | 0.00% | +100.0% |
| Q1 2017 | $442,000 | +75.4% | 85,082 | +3.1% | 0.00% | 0.0% |
| Q4 2016 | $252,000 | -29.4% | 82,533 | +6.9% | 0.00% | 0.0% |
| Q3 2016 | $357,000 | -20.7% | 77,203 | -0.7% | 0.00% | 0.0% |
| Q2 2016 | $450,000 | +2.7% | 77,773 | +7.4% | 0.00% | 0.0% |
| Q1 2016 | $438,000 | -33.3% | 72,403 | +0.6% | 0.00% | -50.0% |
| Q4 2015 | $657,000 | +82.0% | 71,983 | +12.5% | 0.00% | +100.0% |
| Q3 2015 | $361,000 | -51.7% | 64,008 | -5.1% | 0.00% | -50.0% |
| Q2 2015 | $748,000 | -34.2% | 67,470 | -6.9% | 0.00% | -33.3% |
| Q1 2015 | $1,136,000 | +20.5% | 72,465 | +16.8% | 0.00% | 0.0% |
| Q4 2014 | $943,000 | +43.1% | 62,030 | +1.6% | 0.00% | +50.0% |
| Q3 2014 | $659,000 | -33.6% | 61,075 | -6.0% | 0.00% | -33.3% |
| Q2 2014 | $992,000 | -6.9% | 64,950 | +10.3% | 0.00% | 0.0% |
| Q1 2014 | $1,065,000 | +34.1% | 58,884 | +3.0% | 0.00% | +50.0% |
| Q4 2013 | $794,000 | +50.7% | 57,174 | +13.7% | 0.00% | 0.0% |
| Q3 2013 | $527,000 | +32.7% | 50,274 | -1.0% | 0.00% | +100.0% |
| Q2 2013 | $397,000 | – | 50,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |